Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suva ML, Tirosh I (2020) The glioma stem cell model in the era of single-cell genomics. Cancer Cell 37(5):630–636. https://doi.org/10.1016/j.ccell.2020.04.001

Article  CAS  PubMed  Google Scholar 

Armstrong TS, Dirven L, Arons D, Bates A, Chang SM, Coens C, Espinasse C, Gilbert MR et al (2020) Glioma patient-reported outcome assessment in clinical care and research: a response assessment in neuro-oncology collaborative report. Lancet Oncol 21(2):e97–e103. https://doi.org/10.1016/S1470-2045(19)30796-X

Article  PubMed  Google Scholar 

Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang Z, Dai Z, Zhang X et al (2022) Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer 21(1):39. https://doi.org/10.1186/s12943-022-01513-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Statello L, Guo CJ, Chen LL, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96–118. https://doi.org/10.1038/s41580-020-00315-9

Article  CAS  PubMed  Google Scholar 

Graham LD, Pedersen SK, Brown GS, Ho T, Kassir Z, Moynihan AT, Vizgoft EK, Dunne R et al (2011) Colorectal neoplasia differentially expressed (CRNDE), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas. Genes Cancer 2(8):829–840. https://doi.org/10.1177/1947601911431081

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu Y, Sha H, Sun X, Zhang Y, Wu Y, Zhang J, Zhang H, Wu J et al (2020) CRNDE: an oncogenic long non-coding RNA in cancers. Cancer Cell Int 20:162. https://doi.org/10.1186/s12935-020-01246-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma X, Jin W, Zhao C, Wang X, Wang K (2022) CRNDE: a valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies. Mol Ther Nucleic Acids 28:190–201. https://doi.org/10.1016/j.omtn.2022.03.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Z, Wu G, Li J, Wang Y, Ju X, Jiang W (2020) lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC. BMC Cancer 20(1):282. https://doi.org/10.1186/s12885-020-06771-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding Q, Mo F, Cai X, Zhang W, Wang J, Yang S, Liu X (2020) LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway. J Cell Biochem 121(5–6):3358–3371. https://doi.org/10.1002/jcb.29607

Article  CAS  PubMed  Google Scholar 

Chavez-Galan L, Olleros ML, Vesin D, Garcia I (2015) Much more than M1 and M2 macrophages, there are also CD169(+) and TCR(+) macrophages. Front Immunol 6:263. https://doi.org/10.3389/fimmu.2015.00263

Article  CAS  PubMed  PubMed Central  Google Scholar 

Larionova I, Tuguzbaeva G, Ponomaryova A, Stakheyeva M, Cherdyntseva N, Pavlov V, Choinzonov E, Kzhyshkowska J (2020) Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers. Front Oncol 10:566511. https://doi.org/10.3389/fonc.2020.566511

Article  PubMed  PubMed Central  Google Scholar 

Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L (2019) Macrophages and metabolism in the tumor microenvironment. Cell Metab 30(1):36–50. https://doi.org/10.1016/j.cmet.2019.06.001

Article  CAS  PubMed  Google Scholar 

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF et al (2019) The immune landscape of cancer. Immunity 51(2):411–412. https://doi.org/10.1016/j.immuni.2019.08.004

Article  CAS  PubMed  Google Scholar 

Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu XY, Yu ZW, Jia YH et al (2017) The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/beta-catenin signaling. Mol Cancer 16(1):9. https://doi.org/10.1186/s12943-017-0583-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng J, Chen J, Zhang X, Mei H, Wang F, Cai Z (2018) Overexpression of CRNDE promotes the progression of bladder cancer. Biomed Pharmacother 99:638–644. https://doi.org/10.1016/j.biopha.2017.12.055

Article  CAS  PubMed  Google Scholar 

Zhang F, Wang H, Yu J, Yao X, Yang S, Li W, Xu L, Zhao L (2021) LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM. Mol Cancer 20(1):6. https://doi.org/10.1186/s12943-020-01299-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jensen MA, Wilkinson JE, Krainer AR (2014) Splicing factor SRSF6 promotes hyperplasia of sensitized skin. Nat Struct Mol Biol 21(2):189–197. https://doi.org/10.1038/nsmb.2756

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan M, Zhao Z, Arooj S, Fu Y, Liao G (2020) Soluble PD-1: predictive, prognostic, and therapeutic value for cancer immunotherapy. Front Immunol 11:587460. https://doi.org/10.3389/fimmu.2020.587460

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu C, Zhou X, Long Q, Zeng H, Sun Q, Chen Y, Wu D, Liu L (2021) Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene. Oncogene 40(2):233–245. https://doi.org/10.1038/s41388-020-01521-7

Article  CAS  PubMed  Google Scholar 

Zhu Z, Zhang H, Chen B, Liu X, Zhang S, Zong Z, Gao M (2020) PD-L1-mediated immunosuppression in glioblastoma is associated with the infiltration and M2-polarization of tumor-associated macrophages. Front Immunol 11:588552. https://doi.org/10.3389/fimmu.2020.588552

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akins EA, Aghi MK, Kumar S (2020) Incorporating tumor-associated macrophages into engineered models of glioma. iScience 23(12):101770. https://doi.org/10.1016/j.isci.2020.101770

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin S, Xu H, Zhang A, Ni Y, Xu Y, Meng T, Wang M, Lou M (2020) Prognosis analysis and validation of m(6)A signature and tumor immune microenvironment in glioma. Front Oncol 10:541401. https://doi.org/10.3389/fonc.2020.541401

Article  PubMed  PubMed Central  Google Scholar 

Xu S, Tang L, Dai G, Luo C, Liu Z (2020) Expression of m6A regulators correlated with immune microenvironment predicts therapeutic efficacy and prognosis in gliomas. Front Cell Dev Biol 8:594112. https://doi.org/10.3389/fcell.2020.594112

Article  PubMed  PubMed Central  Google Scholar